**vo
**rdisk type 2
diabetes combo drug tops Sa**fi?s Lantus -study
June 7 (Reuters) -
**vo **rdisk's IDegLira combination
drug for
type 2
diabetes led to significant reductions in blood sugar, weight and rate of hypoglycemia compared with Sa**fi's top-selling
Lantus insulin product, according to data from a late-stage trial presented at a medical meeting on Sunday.
